Target intelligence / Profile preview

Liver glucose production (None)

Target
None
Molecular classification
Other (metabolic pathway/process involving multiple enzymes such as glucokinase, glucose-6-phosphatase, phosphoenolpyruvate carboxykinase, fructose 1,6-bisphosphatase)
01

Overview

Liver glucose production encompasses the biochemical processes by which the liver maintains blood sugar levels during fasting or increased energy demand. The two main mechanisms are: 1. Glycogenolysis — breakdown of stored glycogen into free glucose. 2. Gluconeogenesis — synthesis of new glucose molecules from precursors such as lactate, alanine, glycerol. Key enzymatic steps involve conversion between metabolites regulated tightly at transcriptional and post-translational levels. Important enzymes include: - Glucokinase phosphorylates incoming free glucose for intracellular metabolism. - Pyruvate carboxylase converts pyruvate into oxaloacetate initiating gluconeogenic flux. - Phosphoenolpyruvate carboxykinase catalyzes formation of phosphoenolpyruvate from oxaloacetate. - Fructose bisphosphatases regulate rate-limiting steps reversing glycolytic reactions. – Glucose‑6‑phosphatase finalizes dephosphorylation releasing free circulating glucose. Hormonal control plays a critical role with insulin suppressing while glucagon stimulates these pathways. Dysregulation leads to pathological states such as diabetes where excessive hepatic output contributes significantly to hyperglycemia[1][3][5][7]. In summary, "Liver Glucose Production" should be understood as an essential metabolic function rather than an individual molecular target suitable for direct drug binding but remains central in therapeutic strategies aimed at controlling systemic glycemic balance[1][3][5].

Other names
Hepatic glucose outputhepatic gluconeogenesis and glycogenolysis combined
02

Mechanism of action

Drugs targeting this process mainly act by: - Inhibiting key gluconeogenic enzymes or their gene expression - Enhancing insulin signaling to suppress gluconeogenesis/glycogenolysis For example: * Metformin decreases hepatic gluconeogenesis without increasing insulin secretion; exact mechanism remains partially unclear but involves AMP kinase activation and mitochondrial effects. * Insulin inhibits glycogen breakdown and promotes glycogen synthesis in hepatocytes.

03

Biological functions

Glucose homeostasisEnergy metabolismGlycogen metabolismGluconeogenesisGlycolysis regulationFatty acid synthesis linkage via acetyl-CoA supply
04

Disease associations

Diabetes mellitus type 1 and type 2 (excessive hepatic glucose production contributes to hyperglycemia)Obesity-related metabolic dysfunctionsInsulin resistance syndromes
05

Safety considerations

Risk of hypoglycemia when inhibiting liver glucose output excessively.Complex regulation makes selective targeting difficult without affecting other tissues.Side effects from drugs like metformin can include gastrointestinal discomfort; rare lactic acidosis risk.
06

Interacting drugs

Metformin

2 more in the full profile.

07

Biomarkers

Blood plasma levels of fasting blood glucose and postprandial blood sugarHormones regulating this process such as insulin, glucagonEnzyme activity markers like phosphoenolpyruvate carboxykinase expression levels

Beyond the preview

Go deeper on Liver glucose production (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liver glucose production (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call